本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trinity Biotech plc

0.7080
+0.067910.61%
盘后0.72000.0120+1.69%19:39 EDT
成交量:9.18万
成交额:6.29万
市值:1,358.94万
市盈率:-0.31
高:0.7150
开:0.6400
低:0.6300
收:0.6401
数据加载中...
2025/03/26

SEC问询函

Form CORRESP - Correspondence
2024/11/29

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/12

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/05/03

SEC问询函

Form CORRESP - Correspondence
2024/05/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/17

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/25

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]